MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2022 International Congress

    Face Name matching and memory complaints in Parkinson’s disease

    A. Siquier, P. Andrés (Palma, Spain)

    Objective: We aim to portray memory impairment in patients with Parkinson’s disease (PD) from an objective and subjective angle by using an innovative cross-modal associative…
  • 2022 International Congress

    Profile and neural correlates of language disintegration in early Huntington’s disease

    S. Martinez-Horta, A. Puig-Davi, F. Sampedro, J. Perez-Perez, J. Matias-Guiu, A. Horta-Barba, J. Pagonabarraga, M. Diez-Cirarda, L. Fernandez-Romero, M. Yus, F. Cuetos, J. Kulisevsky (Barcelona, Spain)

    Objective: To explore the language profile of early Huntington's disease (HD) and the neural correlates that accompany the development of linguistic alterations in HD. Background:…
  • 2022 International Congress

    White Matter Perivascular Spaces in Parkinson’s Disease are Associated with Decreased Cognition, Interrupted Sleep, and Less Physical Activity

    E. Donahue, S. Venkadesh, R. Foreman, J. Duran, V. Bui, D. Wing, A. Petkus, I. Litvan, E. Bayram, D. Schiehser, J. Choupan, M. Jakowec, G. Petzinger (Los Angeles, USA)

    Objective: To determine the association of Perivascular Spaces (PVS) and non-motor features in Parkinson’s disease (PD). Background: PVS are the fluid-filled spaces surrounding blood vessels…
  • 2022 International Congress

    Cognitive profiles at presentation and subsequent cognitive decline in PD-MCI.

    S. Mirza, S. Duff-Canning, M. Masellis, C. Marras (Toronto, Canada)

    Objective: To determine cognitive profiles in a Parkinson‘s Disease-Mild Cognitive Impairment (PD-MCI) cohort, and study the relationship between baseline cognitive phenotype and subsequent cognitive decline.…
  • 2022 International Congress

    Parkinson’s disease and nucleus basalis of Meynert integrity: Cognition and everyday function

    N. Slater, R. Shoorangiz, G. Hall-Mcmaster, A. Harris, L. Livingston, S. Grenfell, K. Clifford, T. Anderson, T. Melzer, J. Dalrymle-Alford (Christchurch, New Zealand)

    Objective: To examine the association between the integrity of the nucleus basalis of Meynert (NBM), cognition and everyday function in Parkinson’s disease (PD). Background: Most…
  • 2022 International Congress

    NIMHANS Neuropsychological Battery for Elderly in Parkinson’s disease patients: Validation and diagnosis using MDS PD-MCI task force criteria in Indian population

    R. Yadav, R. Botta, K. Kumar, BM. Kutty, A. Mahadevan, PK. Pal (Bengaluru, India)

    Objective: To validate NIMHANS Neuropsychological Battery for Elderly( NNB-E) and evaluate cognitive impairment in Parkinson's disease (PD) patients in comparison with healthy controls. Background: Cognitive…
  • 2022 International Congress

    Cognitive profiling in a cohort of Huntington’s disease (HD) patients

    M. Garon, F. Pistonesi, L. Weis, V. Cianci, T. Gandolfi, E. Fiorenzato, C. Tedesco, M. Campagnolo, M. Carecchio, A. Antonini, R. Biundo (Padua, Italy)

    Objective: To define neuropsychological profile of HD patients adopting Parkinson’s disease Level II criteria for cognitive diagnosis[1]. Background: HD is a rare autosomal dominant genetic…
  • 2022 International Congress

    Predicting the development of dementia in patients with Parkinson’s disease by comparing neurosteroids in the blood level

    DI. Okhunova, G. Sattarovna, A. Babokhujaev (Tashkent, Uzbekistan)

    Objective: To increase the reliability of the development of dementia in patients with PD by a comparative assessment of clinical scales and neurosteroids Background: Parkinson's…
  • 2022 International Congress

    Impaired behavioral proactive inhibitory control and flexibility in a mouse model of early Parkinson’s disease

    J. Lhost, AM. Ouagazzal, M. Liberge, M. Amalric (Marseille, France)

    Objective: The aim of our study is to address the impact of a moderate nigrostriatal DA lesion induced by 6-hydroxydopamine (6-OHDA) injection into the dorsomedial…
  • 2022 International Congress

    The impact of Parkinson’s disease on multifactorial aspects of attention

    O. Peleg, Z. Ktzir, I. Maidan, D. Levy, A. Mirelman (Tel Aviv, Israel)

    Objective: (1) To characterize the differential effects of PD on the two attentional networks and (2) To examine the ability of attentional measurements differentiate between…
  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #25676 (not found)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Welcome to the MDS Abstracts Site
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley